<p><b>(A)</b> Scatter plot showing ADP-induced platelet reactivity by light transmission aggregometry (LTA; x-axis) vs. platelet reactivity by the VerifyNow P2Y<sub>12</sub> assay (y-axis). Circles represent individual measurements. Cut-off values for high on-treatment residual platelet reactivity are indicated by the dotted lines. PRU, P2Y<sub>12</sub> Reaction Units. <b>(B)</b> Scatter plot showing ADP-induced platelet surface P-selectin expression (x-axis) vs. ADP-induced activated glycoprotein (GP) IIb/IIIa (y-axis). Circles represent individual measurements. Cut-off values for high P-selectin and high GPIIb/IIIa are indicated by the dotted lines. <b>(C)</b> Scatter plot showing platelet reactivity by the VerifyNow P2Y<sub>12</sub> assa...
There are many approaches to assessing platelet reactivity and many uses for such measurements. Init...
<p>Washed human platelets were preincubated with (A) 200 µM A<sub>3</sub>P<sub>5</sub>P or vehicle f...
Contains fulltext : 182588.pdf (Publisher’s version ) (Open Access)Patients on P2Y...
<p>Correlations of adenosine diphosphate (ADP)-induced platelet reactivity by light transmission agg...
<p><b>(A)</b> Scatter plot showing AA-induced platelet reactivity by light transmission aggregometry...
Data on the agreement between aggregometry and platelet activation by flow cytometry re-garding the ...
<p>Comparison of the AUC after ADP stimulation between low (n = 122) versus high levels of platelet-...
© 2018, Springer Science+Business Media, LLC, part of Springer Nature. A number of techniques have b...
<p>Platelet rich plasma was pre-treated with 0.31 µM PGE1 or 1 mM adenosine 3’, 5’-diphosphate (A3P5...
<p>Pharmacodynamic profile showing ADP induced platelet aggregation over time according to treatment...
1. The platelet responses to adenosine 5'-diphosphate (ADP) and ADP-induced signal transduction invo...
<p>Light transmission aggregometry induced with 10 μM ADP was measured in washed platelets (3 x 10<s...
Data on the agreement between aggregometry and platelet activation by flow cytometry regarding the m...
<p>Increase in platelet activation marker A. PAC-1 (activated glycoprotein IIb/IIIa) and B. P-select...
<p>(A, B) Western blot analysis of phosphorylated p-p38 and p-Akt in platelets stimulated with ADP (...
There are many approaches to assessing platelet reactivity and many uses for such measurements. Init...
<p>Washed human platelets were preincubated with (A) 200 µM A<sub>3</sub>P<sub>5</sub>P or vehicle f...
Contains fulltext : 182588.pdf (Publisher’s version ) (Open Access)Patients on P2Y...
<p>Correlations of adenosine diphosphate (ADP)-induced platelet reactivity by light transmission agg...
<p><b>(A)</b> Scatter plot showing AA-induced platelet reactivity by light transmission aggregometry...
Data on the agreement between aggregometry and platelet activation by flow cytometry re-garding the ...
<p>Comparison of the AUC after ADP stimulation between low (n = 122) versus high levels of platelet-...
© 2018, Springer Science+Business Media, LLC, part of Springer Nature. A number of techniques have b...
<p>Platelet rich plasma was pre-treated with 0.31 µM PGE1 or 1 mM adenosine 3’, 5’-diphosphate (A3P5...
<p>Pharmacodynamic profile showing ADP induced platelet aggregation over time according to treatment...
1. The platelet responses to adenosine 5'-diphosphate (ADP) and ADP-induced signal transduction invo...
<p>Light transmission aggregometry induced with 10 μM ADP was measured in washed platelets (3 x 10<s...
Data on the agreement between aggregometry and platelet activation by flow cytometry regarding the m...
<p>Increase in platelet activation marker A. PAC-1 (activated glycoprotein IIb/IIIa) and B. P-select...
<p>(A, B) Western blot analysis of phosphorylated p-p38 and p-Akt in platelets stimulated with ADP (...
There are many approaches to assessing platelet reactivity and many uses for such measurements. Init...
<p>Washed human platelets were preincubated with (A) 200 µM A<sub>3</sub>P<sub>5</sub>P or vehicle f...
Contains fulltext : 182588.pdf (Publisher’s version ) (Open Access)Patients on P2Y...